PR Stardots CEO Daniel Petrini speaks at MATLAB Expo in November

Uppsala, Sweden – October 30, 2025 – Stardots AB – a leading developer of software medical devices to simplify and improve the diagnosis and treatment of neurological and psychiatric disorders – today announces that the company’s CEO Daniel Petrini has been invited to speak at MATLAB Expo, a premier global event for innovators and engineers advancing AI and simulation technology. On November 12, Daniel will present to an audience of over 12,000 scientists, investors and industry leaders, demonstrating how Stardots’ ANLIVA® platform and Psilmi™ technology are advancing the fields of neurology and psychiatry.

Organized by MathWorks, MATLAB Expo attracts senior decision-makers and innovators from aerospace, automotives, healthcare, and technology sectors – industries at the forefront of AI and advanced computational applications. For Stardots, this represents a strategic platform to reach technical experts working with cutting-edge modeling solutions, as well as investors seeking innovation in this space.

During a session at MATLAB Expo, Daniel Petrini will present Stardots’ ANLIVA platform and Psilmi technology. ANLIVA is a Software as Medical Device (SaMD) that employs advanced mathematical modeling, aiming to make the treatment of Parkinson’s disease smarter – from eye movements to brain signals. Psilmi is an AI driven medical device for psychiatry using biological measurements developed as a diagnostics and intervention aid to support autism and ADHD diagnosis.

“This is an invaluable opportunity to showcase our technology to thousands of industry leaders at MATLAB Expo who recognize the potential of computational modeling in healthcare. Our platform’s cloud-independent microservice architecture with modeling developed in MATLAB, positions us at the intersection of advanced mathematics and precision medicine,” says Daniel Petrini, CEO of Stardots.

The session, titled “Advancing neurology with MATLAB powered precision medicine”, takes place on November 12, 11:30 AM CET. Access is free of charge: https://www.matlabexpo.com/online/2025.html

For further information, please contact:
Daniel Petrini, CEO
Tel: +46 70-782 70 01
E-mail: daniel.petrini@stardots.se

About Stardots AB

Stardots AB develops software-based diagnostic tools (Software as Medical Device) for neurological and psychiatric disorders such as Parkinson’s, autism, ADHD, dementia and Alzheimer’s. The company’s product platforms ANLIVA®, Psilmi™ and QUEST® use advanced mathematical modeling of sensor data from smartphones, eye cameras and other sensors to enable faster and more reliable diagnosis and optimized treatment. Stardots’ first products, ANLIVA® Hand and Eye Movement for Parkinson’s disease, is currently being evaluated in a clinical trial in collaboration with Dartmouth Hitchcock Medical Center in the U.S. Stardots, headquartered in Uppsala, Sweden, has the U.S. as its primary target market.

For further information, visit www.stardots.se.